Flonase Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS 100/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2023 Category: Research Source Type: clinical trials

A Phase III Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK;   Drug: Placebo Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2022 Category: Research Source Type: clinical trials